<DOC>
	<DOCNO>NCT01356212</DOCNO>
	<brief_summary>This randomise three-way crossover design study . The study consist three study period separate minimum 44 hour washout period . During course study period , scintigraphic image acquire planned interval dose . Subjects able leave clinical unit completion study specific procedures 6 hour post-dose . The primary objective study determine whether radiolabelled ketorolac formulation deposit lung healthy volunteer follow nasal inhalation three different condition ( gentle sniff-inhalation subject standing , vigorous sniff-inhalation subject standing , gentle sniff-inhalation subject semi-supine ) . The secondary objective determine deposition pattern radiolabelled ketorolac solution nasal cavity , clearance radiolabel six-hour period .</brief_summary>
	<brief_title>Assessment Nasal Deposition Clearance Ketorolac Solution Administered Using Valois Nasal Spray Device</brief_title>
	<detailed_description />
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>Healthy male nonpregnant , nonlactating , surgically sterile postmenopausal female ( postmenopausal define &gt; 2 year postlast period 50 year age ) , use acceptable form contraception define section 9.3.2 ( g ) Aged 1865 year Body Mass Index 18 30 kg/m2 Participation clinical research study involve investigational drug dosage form within previous 4 month Subjects seek advice GP consult counsellor abuse misuse alcohol , nonmedical , medicinal drug , substanceabuse solvent . Any current past use Class A drug opiates , ecstasy , LSD , amphetamine ( Class B ) . Volunteers admit past use cannabis exclude long negative drug abuse test abstinent least 12 month Positive drug abuse test result Regular alcohol consumption male &gt; 21 unit per week female &gt; 14 unit per week . ( one unit alcohol define 0.5 pint ( 280 ml ) beer cider , 1 glass ( 125 ml ) wine , 1 glass ( 70 ml ) sherry port , 1 measure ( 25 ml ) whisky , brandy rum . For low alcohol drink , one unit alcohol define 2 glass ( 250 ml ) low alcohol wine 5 half pint ( 840 ml ) low alcohol beer ) Current smoker , i.e . smoke within last 12 month A breath carbon monoxide read great 10 ppm either prestudy medical examination study day prior dose Females child bear potential sexually active either surgically sterile , postmenopausal use form acceptable contraceptive ( contraceptive pills/injection , condom spermicide , IUCDs ( coil ) diaphragms spermicide ( woman 35 ) abstinence Radiation exposure clinical trial , include present study diagnostic Xrays exclude background radiation , exceed 5 mSv last twelve month 10 mSv last five year . No subject whose occupational exposure monitor participate study Clinically significant abnormal biochemistry , haematology urinalysis Screening FEV1 &lt; 80 % predict value age , sex , height race History chronic respiratory disorder bronchospasm History adverse reaction allergy ketorolac disodium EDTA History severe multiple allergy , include hayfever perennial rhinitis History adverse reaction allergy aspirin nonsteroidal anti inflammatory drug ( e.g. , ibuprofen , flurbiprofen , ketoprofen diclofenac ) History infantile bronchiolitis , history presence asthma , wheezy respiration , hayfever perennial rhinitis History nasal fracture , nasal deformity nasal polyps History disease , surgery , abnormality upper respiratory tract , especially nasal cavity History significant nose bleeds Sinusitis within four week first study period Nasal jewelry nasal piercings Subjects use topical nasal medication e.g . decongestant , within 14 day prior first dose day Upper respiratory tract infection ( exclude otitis medium ) within 14 day first study day , low respiratory tract infection within previous 3 month Subjects take medication might affect respiratory tract within 14 day first study day Nonprescription prescription medication ( include vitamin natural herbal remedy eg . St Johns Wort ) within 14 day first study day ( oral contraceptive , contraceptive implant depot injection , intrauterine device hormonal implant , Hormone Replacement Therapy ( HRT ) occasional paracetamol ( 4 g daily ) permit ) History peptic ulceration gastrointestinal bleeding History kidney disease History clot disorder Failure satisfy Principal Medical Investigator fitness participate reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>